Literature DB >> 15590972

Co-localization of nestin and insulin and expression of islet cell markers in long-term human pancreatic nestin-positive cell cultures.

Silvya Stuchi Maria-Engler1, Maria Lúcia C Corrêa-Giannella, Letícia Labriola, Karin Krogh, Christian Colin, Fernando Henrique Lojudice, Carlos Alberto Mayora Aita, Elizabeth Maria Costa de Oliveira, Tatiana C Silveira Corrêa, Irenice Cairo da Silva, Tercio Genzini, Marcelo Perosa de Miranda, Irene Lourdes Noronha, Luciano Vilela, Cassio Negro Coimbra, Renato A Mortara, Marcos Mares Guia, Freddy Goldberg Eliaschewitz, Mari Cleide Sogayar.   

Abstract

Strategies to differentiate progenitor cells into beta cells in vitro have been considered as an alternative to increase beta cell availability prior to transplantation. It has recently been suggested that nestin-positive cells could be multipotential stem cells capable of expressing endocrine markers upon specific stimulation; however, this issue still remains controversial. Here, we characterized short- and long-term islet cell cultures derived from three different human islet preparations, with respect to expression of nestin and islet cell markers, using confocal microscopy and semi-quantitative RT-PCR. The number of nestin-positive cells was found to be strikingly high in long-term cultures. In addition, a large proportion (49.7%) of these nestin-positive cells, present in long-term culture, are shown to be proliferative, as judged by BrdU incorporation. The proportion of insulin-positive cells was found to be high in short-term (up to 28 days) cultures and declined thereafter, when cells were maintained in the presence of 10% serum, concomitantly with the decrease in insulin and PDX-1 expression. Interestingly, insulin and nestin co-expression was observed as a rare event in a small proportion of cells present in freshly isolated human islets as well as in purified islet cells cultured in vitro for long periods of time. In addition, upon long-term subculturing of nestin-positive cells in 10% serum, we observed reappearance of insulin expression at the mRNA level; when these cultures were shifted to 1% serum for a month, expression of insulin, glucagon and somatostatin was also detected, indicating that manipulating the culture conditions can be used to modulate the nestin-positive cell's fate. Attempts to induce cell differentiation by plating nestin-positive cells onto Matrigel revealed that these cells tend to aggregate to form islet-like clusters, but this is not sufficient to increase insulin expression upon short-term culture. Our data corroborate previous findings indicating that, at least in vitro, nestin-positive cells may undergo the early stages of differentiation to an islet cell phenotype and that long-term cultures of nestin-positive human islet cells may be considered as a potential source of precursor cells to generate fully differentiated/ functional beta cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15590972     DOI: 10.1677/joe.1.05703

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

1.  Nestin action during insulin-secreting cell differentiation.

Authors:  So-Yoon Kim; Song Lee; Seok-Woo Hong; Bon-Hong Min; Ki-Up Lee; Moise Bendayan; In-Sun Park
Journal:  J Histochem Cytochem       Date:  2010-03-02       Impact factor: 2.479

Review 2.  Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.

Authors:  A E Barcala Tabarrozzi; C N Castro; R A Dewey; M C Sogayar; L Labriola; M J Perone
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

3.  Differentiation Potential of Nestin (+) and Nestin (-) Cells Derived from Human Bone Marrow Mesenchymal Stem Cells into Functional Insulin Producing Cells.

Authors:  Sahar Rashed; Mahmoud Gabr; Abdel-Aziz Abdel-Aziz; Mahmoud Zakaria; Sherry Khater; Amani Ismail; Ali Fouad; Ayman Refaie
Journal:  Int J Mol Cell Med       Date:  2019-07-17

Review 4.  Insulin producing cells derived from embryonic stem cells: are we there yet?

Authors:  Sudhanshu P Raikwar; Nicholas Zavazava
Journal:  J Cell Physiol       Date:  2009-02       Impact factor: 6.384

Review 5.  NUCEL (Cell and Molecular Therapy Center): a multidisciplinary center for translational research in Brazil.

Authors:  C Colin; M A Demasi; T L Degaki; J C Bustos-Valenzuela; R C S Figueira; W R Montor; L O Cruz; F H Lojudice; A G Muras; T M Pereira; S M B Winnischofer; A P G Hasegawa; A C Carreira; N V Verbisck; R G Corrêa; H M Garay-Malpartida; T R Mares-Guia; M L Corrêa-Giannella; J M Granjeiro; M C Sogayar
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

Review 6.  Development of the endocrine pancreas and novel strategies for β-cell mass restoration and diabetes therapy.

Authors:  A L Márquez-Aguirre; A A Canales-Aguirre; E Padilla-Camberos; H Esquivel-Solis; N E Díaz-Martínez
Journal:  Braz J Med Biol Res       Date:  2015-07-10       Impact factor: 2.590

7.  The diagnostic importance of matrix metalloproteinase-7 and nestin in gastrointestinal stromal tumors.

Authors:  Kemal Peker; Ilyas Sayar; Ibrahim Gelincik; Gülay Bulut; Tuba Dilay Kökenek Ünal; Serkan Şenol; Aysun Gökçe; Arda Isik
Journal:  Med Sci Monit       Date:  2014-04-23

8.  High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.

Authors:  Aline Ramos Maia Lobba; Ana Claudia Oliveira Carreira; Otto Luiz Dutra Cerqueira; André Fujita; Carlos DeOcesano-Pereira; Cynthia Aparecida Bueno Osorio; Fernando Augusto Soares; Pranela Rameshwar; Mari Cleide Sogayar
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.